Japanese Pharmaceuticals & Biotech Potentially Undervalued Companies

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Towa Pharmaceutical

Market Cap: JP¥118.7b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

Tsumura

Market Cap: JP¥309.0b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Sumitomo Pharma

Market Cap: JP¥205.0b

Engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally.

Ono Pharmaceutical

Market Cap: JP¥764.4b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Astellas Pharma

Market Cap: JP¥2.3t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Shionogi

Market Cap: JP¥1.8t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

PeptiDream

Market Cap: JP¥241.5b

A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Fuji Pharma

Market Cap: JP¥31.0b

Engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥59.7b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Daito PharmaceuticalLtd

Market Cap: JP¥32.2b

Manufactures and sells pharmaceutical products worldwide.

Zeria Pharmaceutical

Market Cap: JP¥96.3b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally.

Takeda Pharmaceutical

Market Cap: JP¥6.0t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.

CellSource

Market Cap: JP¥12.3b

Engages in the regenerative medicine-related businesses in Japan.

Daiichi Sankyo Company

Market Cap: JP¥5.8t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Linical

Market Cap: JP¥6.6b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Takara Bio

Market Cap: JP¥91.9b

Engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally.

Santen Pharmaceutical

Market Cap: JP¥442.0b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.1t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

JCR Pharmaceuticals

Market Cap: JP¥51.3b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

WDB coco

Market Cap: JP¥7.8b

Provides contract services to pharmaceutical companies in Japan.

Kohjin Bio

Market Cap: JP¥8.2b

Manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics.

Japan Tissue Engineering

Market Cap: JP¥17.1b

Engages in the regenerative medicine business in Japan.

Astena Holdings

Market Cap: JP¥17.5b

Manufactures and sells medicine-related products in Japan.

Sawai Group Holdings

Market Cap: JP¥215.0b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Human Metabolome Technologies

Market Cap: JP¥4.0b

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan.

Solasia Pharma K.K

Market Cap: JP¥7.0b

Engages in the development and marketing of oncology drugs in Japan and other Asian countries.

RaQualia Pharma

Market Cap: JP¥7.3b

Engages in the research and development of pharmaceutical compounds worldwide.

Kissei Pharmaceutical

Market Cap: JP¥151.5b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Eisai

Market Cap: JP¥1.0t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥52.5b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Nippon Shinyaku

Market Cap: JP¥230.8b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Hisamitsu Pharmaceutical

Market Cap: JP¥312.7b

Manufactures and sells pharmaceuticals in Japan.